Easy Raw Fudge
½ cup butter (softened) (raw, organic is best if you can get it)
1 cup arrow root powder (less expensive in oriental stores)
*½ cup almond milk (or rice milk or coconut milk)
1 cup raw, organic carob
1 tsp. pure, organic vanilla
1 cup walnuts (optional)
1 cup of the best quality unsweetened coconut you can find.
Mix together and roll into bite size balls.
Enjoy!
*To make almond milk, soak almonds overnight, place ¼ cup almonds with 1 cup warm water in blender. Blend until smooth. (Can be strained, if you prefer.)
Monday, December 19, 2005
Thursday, December 1, 2005
Artificial Sweetener Causes Cancer
New Study Suggests Artificial Sweetener Causes Cancer in Rats at Levels Currently Approved for Humans
Report in Environmental Health Perspectives calls for reevaluation of acceptable limits of aspartame consumption
[Research Triangle Park, NC] ] A statistically significant increase in the incidence of malignant tumors, lymphomas and leukemias in rats exposed to varying doses of aspartame appears to link the artificial sweetener to a high carcinogenicity rate, according to a study accepted for publication today by the peer-reviewed journal Environmental Health Perspectives (EHP). The authors of the study, the first to demonstrate multipotential carcinogenic effects of aspartame administered to rats in feed, called for an "urgent reevaluation" of the current guidelines for the use and consumption of this compound.
"Our study has shown that aspartame is a multipotential carcinogenic compound whose carcinogenic effects are also evident at a daily dose of 20 milligrams per kilogram of body weight (mg/kg), notably less than the current acceptable daily intake for humans," the authors write. Currently, the acceptable daily intake for humans is set at 50 mg/kg in the United States and 40 mg/kg in Europe.
Aspartame is the second most widely used artificial sweetener in the world. It is found in more than 6,000 products including carbonated and powdered soft drinks, hot chocolate, chewing gum, candy, desserts, yogurt, and tabletop sweeteners, as well as some pharmaceutical products like vitamins and sugar-free cough drops. More than 200 million people worldwide consume it. The sweetener has been used for more than 30 years, having first been approved by the FDA in 1974. Studies of the carcinogenicity of aspartame performed by its producers have been negative.
Researchers administered aspartame to Sprague-Dawley rats by adding it to a standard diet. They began studying the rats at 8 weeks of age and continued until the spontaneous death of each rat. Treatment groups received feed that contained concentrations of aspartame at dosages simulating human daily intakes of 5,000, 2,500, 500, 100, 20, and 4 mg/kg body weight. Groups consisted of 100 males and 100 females at each of the three highest dosages and 150 males and 150 females at all lower dosages and controls.
The experiment ended after the death of the last animal at 159 weeks. At spontaneous death, each animal underwent examination for microscopic changes in all organs and tissues, a process different from the aspartame studies conducted 30 years ago and one that was designed to allow aspartame to fully express any carcinogenic potential.
The treated animals showed extensive evidence of malignant cancers including lymphomas, leukemias, and tumors at multiple organ sites in both males and females. The authors speculate the increase in lymphomas and leukemias may be related to one of the metabolites in aspartame, namely methanol, which is metabolized in both rats and humans to formaldehyde. Both methanol and formaldehyde have shown links to lymphomas and leukemias in other long-term experiments by the same authors.
The current study included more animals over a longer period than earlier studies. "In our opinion, previous studies did not comply with today's basic requirements for testing the carcinogenic potential of a physical or chemical agent, in particular concerning the number of rodents for each experimental group (40-86, compared to 100-150 in the current study) and the termination of previous studies at only 110 weeks of age of the animals," the study authors wrote.
The authors of the study were Morando Soffritti, Fiorella Belpoggi, Davide Degli Esposti, Luca Lambertini, Eva Tibaldi, and Anna Rigano of the Cesare Maltoni Cancer Research Center, European Ramazzini Foundation of Oncology and Environmental Sciences, Bologna, Italy. Funding for the research was provided by the European Ramazzini Foundation of Oncology and Environmental Sciences, Bologna, Italy. The article is available free of charge at http://ehp.niehs.nih.gov/docs/2005/8711/abstract.html.
EHP is published by the National Institute of Environmental Health Sciences (NIEHS), part of the U.S. Department of Health and Human Services. EHP EHP is an Open Access journal. More information is available online at http://www.ehponline.org/. Brogan & Partners Convergence Marketing handles marketing and public relations for EHP, and is responsible for creation and distribution of this press release.
Report in Environmental Health Perspectives calls for reevaluation of acceptable limits of aspartame consumption
[Research Triangle Park, NC] ] A statistically significant increase in the incidence of malignant tumors, lymphomas and leukemias in rats exposed to varying doses of aspartame appears to link the artificial sweetener to a high carcinogenicity rate, according to a study accepted for publication today by the peer-reviewed journal Environmental Health Perspectives (EHP). The authors of the study, the first to demonstrate multipotential carcinogenic effects of aspartame administered to rats in feed, called for an "urgent reevaluation" of the current guidelines for the use and consumption of this compound.
"Our study has shown that aspartame is a multipotential carcinogenic compound whose carcinogenic effects are also evident at a daily dose of 20 milligrams per kilogram of body weight (mg/kg), notably less than the current acceptable daily intake for humans," the authors write. Currently, the acceptable daily intake for humans is set at 50 mg/kg in the United States and 40 mg/kg in Europe.
Aspartame is the second most widely used artificial sweetener in the world. It is found in more than 6,000 products including carbonated and powdered soft drinks, hot chocolate, chewing gum, candy, desserts, yogurt, and tabletop sweeteners, as well as some pharmaceutical products like vitamins and sugar-free cough drops. More than 200 million people worldwide consume it. The sweetener has been used for more than 30 years, having first been approved by the FDA in 1974. Studies of the carcinogenicity of aspartame performed by its producers have been negative.
Researchers administered aspartame to Sprague-Dawley rats by adding it to a standard diet. They began studying the rats at 8 weeks of age and continued until the spontaneous death of each rat. Treatment groups received feed that contained concentrations of aspartame at dosages simulating human daily intakes of 5,000, 2,500, 500, 100, 20, and 4 mg/kg body weight. Groups consisted of 100 males and 100 females at each of the three highest dosages and 150 males and 150 females at all lower dosages and controls.
The experiment ended after the death of the last animal at 159 weeks. At spontaneous death, each animal underwent examination for microscopic changes in all organs and tissues, a process different from the aspartame studies conducted 30 years ago and one that was designed to allow aspartame to fully express any carcinogenic potential.
The treated animals showed extensive evidence of malignant cancers including lymphomas, leukemias, and tumors at multiple organ sites in both males and females. The authors speculate the increase in lymphomas and leukemias may be related to one of the metabolites in aspartame, namely methanol, which is metabolized in both rats and humans to formaldehyde. Both methanol and formaldehyde have shown links to lymphomas and leukemias in other long-term experiments by the same authors.
The current study included more animals over a longer period than earlier studies. "In our opinion, previous studies did not comply with today's basic requirements for testing the carcinogenic potential of a physical or chemical agent, in particular concerning the number of rodents for each experimental group (40-86, compared to 100-150 in the current study) and the termination of previous studies at only 110 weeks of age of the animals," the study authors wrote.
The authors of the study were Morando Soffritti, Fiorella Belpoggi, Davide Degli Esposti, Luca Lambertini, Eva Tibaldi, and Anna Rigano of the Cesare Maltoni Cancer Research Center, European Ramazzini Foundation of Oncology and Environmental Sciences, Bologna, Italy. Funding for the research was provided by the European Ramazzini Foundation of Oncology and Environmental Sciences, Bologna, Italy. The article is available free of charge at http://ehp.niehs.nih.gov/docs/2005/8711/abstract.html.
EHP is published by the National Institute of Environmental Health Sciences (NIEHS), part of the U.S. Department of Health and Human Services. EHP EHP is an Open Access journal. More information is available online at http://www.ehponline.org/. Brogan & Partners Convergence Marketing handles marketing and public relations for EHP, and is responsible for creation and distribution of this press release.
Saturday, November 26, 2005
New Echinacea Study Not Relevant to Informed Practice
When you are searching for an effective echinacea product, contact the leaflady. Our echinacea is made from root and flowers of fresh herb plants and has been proven to be highly effective.
Now for the hype to keep you from good natural health products -
A much publicized article recently featured in the New England Journal of Medicine claims to establish that Echinacea has no effect in the prevention and treatment of the common cold. In the study, the authors compared the effect of different preparations of Echinacea angustifolia root on rhinovirus infection. The infection was artificially induced using a strain of rhinovirus type 39 which is considered to be safe. The dose of Echinacea root used was 900 mg per day for 7 days before the virus challenge and then 5 days after. The study evaluated both preventative and treatment effects of the various Echinacea preparations on the rhinovirus infection and found no significant results for either. An important consideration was that the dose was not adjusted for the acute infection phase of the study. The Echinacea angustifolia root was extracted under different conditions in order to compare the effects of the different phytochemical profiles that are typically found in Echinacea products.
The study has been widely condemned, especially in terms of the low dose of Echinacea used. To put this in perspective, the daily amount of Echinacea used in the trial was the equivalent of around one half of a MediHerb Echinacea Premium tablet. (This assumes that the extract the authors made themselves was at least comparable to the patented product we produce under pharmaceutical GMP. Since we have tested products worldwide and found not one that even comes near the levels of alkylamides in Echinacea Premium, this assumption in the authors’ favor is unlikely to be the case, making the relative dose used in the trial even lower). In contrast, MediHerb recommends 2 tablets per day as a preventative dose for immune support and 3 to 4 times this amount (6 to 8 tablets) during acute infections. No wonder the study found no benefit from the low dose of Echinacea used. It is like taking one quarter of a headache tablet and wondering why your headache is still there.
In defense of the dose used, Dr. Ronald Turner has recently claimed that: “There is no evidence from prior studies that the dose of Echinacea would have changed the outcome…”. But, in fact, a study published as far back as 1992 suggests that this is not the case. In a randomized, double-blind, placebo-controlled trial, 180 patients with upper respiratory tract infections received the equivalent of 1800 mg per day or 900 mg per day of E. purpurea root as a tincture, or placebo. Patients receiving the high dose experienced significant relief of symptoms. However patients receiving the lower dose (900 mg) were not significantly different from the placebo control. Also the doses recommended in professional herb texts are clearly higher than 900 mg per day.
Even one of the article’s authors has acknowledged that the amount of Echinacea used in the study may have been insufficient. David Gangemi, PhD, of Clemson University responded to a question posed about this research at last month’s Medicines from the Earth Symposium in North Carolina by stating, “I think in retrospect if we go back and we look at some of the other products that are out there maybe we're only one tenth the level we should be.”
Another aspect of this study which limits the generalization of its results to all users of Echinacea was that an artificial infection was induced in young, healthy volunteers. This could be irrelevant to the real life situation where people with compromised immunity are exposed to a range of constantly evolving viruses and bacteria.
Unfortunately, this trial represents a waste of money and a missed opportunity to better understand the real clinical value of Echinacea.
If only someone had asked an herbalist!
Now for the hype to keep you from good natural health products -
A much publicized article recently featured in the New England Journal of Medicine claims to establish that Echinacea has no effect in the prevention and treatment of the common cold. In the study, the authors compared the effect of different preparations of Echinacea angustifolia root on rhinovirus infection. The infection was artificially induced using a strain of rhinovirus type 39 which is considered to be safe. The dose of Echinacea root used was 900 mg per day for 7 days before the virus challenge and then 5 days after. The study evaluated both preventative and treatment effects of the various Echinacea preparations on the rhinovirus infection and found no significant results for either. An important consideration was that the dose was not adjusted for the acute infection phase of the study. The Echinacea angustifolia root was extracted under different conditions in order to compare the effects of the different phytochemical profiles that are typically found in Echinacea products.
The study has been widely condemned, especially in terms of the low dose of Echinacea used. To put this in perspective, the daily amount of Echinacea used in the trial was the equivalent of around one half of a MediHerb Echinacea Premium tablet. (This assumes that the extract the authors made themselves was at least comparable to the patented product we produce under pharmaceutical GMP. Since we have tested products worldwide and found not one that even comes near the levels of alkylamides in Echinacea Premium, this assumption in the authors’ favor is unlikely to be the case, making the relative dose used in the trial even lower). In contrast, MediHerb recommends 2 tablets per day as a preventative dose for immune support and 3 to 4 times this amount (6 to 8 tablets) during acute infections. No wonder the study found no benefit from the low dose of Echinacea used. It is like taking one quarter of a headache tablet and wondering why your headache is still there.
In defense of the dose used, Dr. Ronald Turner has recently claimed that: “There is no evidence from prior studies that the dose of Echinacea would have changed the outcome…”. But, in fact, a study published as far back as 1992 suggests that this is not the case. In a randomized, double-blind, placebo-controlled trial, 180 patients with upper respiratory tract infections received the equivalent of 1800 mg per day or 900 mg per day of E. purpurea root as a tincture, or placebo. Patients receiving the high dose experienced significant relief of symptoms. However patients receiving the lower dose (900 mg) were not significantly different from the placebo control. Also the doses recommended in professional herb texts are clearly higher than 900 mg per day.
Even one of the article’s authors has acknowledged that the amount of Echinacea used in the study may have been insufficient. David Gangemi, PhD, of Clemson University responded to a question posed about this research at last month’s Medicines from the Earth Symposium in North Carolina by stating, “I think in retrospect if we go back and we look at some of the other products that are out there maybe we're only one tenth the level we should be.”
Another aspect of this study which limits the generalization of its results to all users of Echinacea was that an artificial infection was induced in young, healthy volunteers. This could be irrelevant to the real life situation where people with compromised immunity are exposed to a range of constantly evolving viruses and bacteria.
Unfortunately, this trial represents a waste of money and a missed opportunity to better understand the real clinical value of Echinacea.
If only someone had asked an herbalist!
Sunday, November 13, 2005
FLU VACCINE (Tamiflu) KILLS TWO TEENS
TOKYO - Two teenage boys who took the antiviral drug Tamiflu exhibited abnormal behavior that led to their deaths, with one jumping in front of an oncoming truck last year and the other falling from the ninth floor of a building earlier this year, health ministry and other sources said Saturday.
The drug in Japan carries a note listing impaired consciousness, abnormal behaviors, hallucination and other psychological and neurological symptoms as possible serious side effects. The ministry is considering making a fresh warning about them, following its decision to increase the stockpile of the drug amid growing fears about a possible pandemic of a new type of influenza as bird flu deaths rise across Asia.
© 2005 Kyodo News. All rights reserved.
http://www.japantoday.com/e/?content=news&cat=1&id=355181
Mercury (CAS#7439-97-6)
Sources of exposure: Mercury occurs primarily in two forms: organic mercury and inorganic mercury. Inorganic mercury occurs when elemental mercury is combined with chlorine, sulfur, or oxygen. Inorganic mercury and elemental mercury are both toxins that can produce a wide range of adverse health affects. Inorganic mercury is used in thermometers, barometers, dental fillings, batteries, electrical wiring and switches, fluorescent light bulbs, pesticides, fungicides, vaccines, paint, skin-tightening creams, vapors from spills, antiseptic creams, pharmaceutical drugs and ointments (Thimerisol is the mercury used in vaccines) (ATSDR, 1989a). Inorganic mercury vapor is at high concentrations near chlorine-alkali plants, smelters, municipal incinerators and sewage treatment plants. The organic form occurs when mercury is combined with carbon. The most common form of organic mercury is methyl mercury, which is produced primarily by small organisms in water and soil when they are exposed to inorganic mercury. Humans also have the ability to convert inorganic mercury to an organic form once it has become absorbed into the bloodstream. Organic mercury is known to bioaccumulate -- or pass up the food chain due an organism's inability to process and eliminate it. It is found primarily in marine life (fish), and can often be found in produce and farm animals, processed grains and dairy products, and surface, salt-, and fresh water sources (ATSDR, 1989a; Brenner and Snyder, 1980). Occupational exposure to mercury containing compounds presents a significant health risk to individuals. Dentists, painters, fisherman, electricians, pharmaceutical/laboratories workers, farmers, factory workers, miners, chemists and beauticians are just some of the professions chronically exposed to mercury compounds.
Target tissues: The absorption and distribution of mercury compounds depends largely upon its chemical state. Organic mercury compounds are absorbed from the gastrointestinal tract more readily than inorganic mercury compounds, with the latter being very poorly absorbed. After absorption in the gastrointestinal tract, organic mercury is readily distributed throughout the body but tends to concentrate in the brain and kidneys (Goyer, 1991b). Approximately 80% of mercury vapor is absorbed directly through the lungs and distributed primarily to the CNS and the kidneys (Friberg and Nordberg, 1973). Inorganic and organic forms of mercury have also been seen in the red blood cells, liver, muscle tissue, and gall bladder (Peterson et al., 1991, Dutczak et al., 1991, ATSDR 1989a).
Signs and symptoms: Mercury exposure can result in a wide variety of human health conditions. The degree of impairment and the clinical manifestations that accompany mercury exposure largely depend upon its chemical state and the route of exposure. While inorganic mercury compounds are considered less toxic than organic mercury compounds (primarily due to difficulties in absorption), inorganic mercury that is absorbed is readily converted to an organic form by physiological processes in the liver.
The acute ingestion of inorganic mercury salts may cause gastrointestinal disorders such as abdominal pain, vomiting, diarrhea, and hemorrhage (ATSD 1989a). Repeated and prolonged exposure has resulted in severe disturbances in the central nervous system, gastrointestinal tract, kidneys, and liver. Daivs et al. (1974) reported dementia, colitis, and renal failure in individuals chronically poisoned due to the ingestion of an inorganic mercury containing laxative. Inhaled inorganic mercury can cause a wide range of clinical complications in individuals including corrosive bronchitis, interstitial pneumonitis, renal disorders, fatigue, insomnia, loss of memory, excitability, chest pains, impairment of pulmonary function and gingivitis (Goyer 1991b, ATSDR 1989a). Chronic inhalation of inorganic mercury compounds may result in a reduction of sensory and motor nerve function, depression, visual and/or auditory hallucinations, muscular tremors, sleep disorders, alterations in autonomic function (heart rate, blood pressure, reflexes), impaired visuomotor coordination, speech disorders, dementia, coma and death (Clarkson 1989; Goyer 1991b; Fawyer et al. 1983; Piikivi and Hanninen 1989; and Ngim et al. 1992). Ngim et al. (1992) have shown that a group of dentists exposed to mercury vapors occupationally perform significantly worse in neurobehavioral tests that measure motor speed, visual scanning, visuomotor coordination and concentration, verbal memory and visual memory. Kishi et al. (1993) have found that smelter workers exposed to inorganic mercury compounds continue to experience neurological symptoms-tremors, headaches, slurred speech-senile symptoms and diminished mental capacities eighteen years after the cessation of mercury exposure.
Our understanding of the effects of methyl mercury poisoning comes primarily from epidemic poisonings in Iraq and Japan. In iraq, more than 6,000 individuals were hospitalized and 459 died as a result of methyl mercury poisoning. Adults experienced symptoms including parasthesia, visual disorders, ataxia, fatigue, tremor, hearing disorders (deafness) and coma (Bakir et al., 1973; Mottet, Shaw, and Burbacher, 1985). Neuropathologic observations of exposed individuals have shown irreversible brain damage including neuronal necrosis, cerebral edema, gliosis, and cerebral atrophy (Mottet, Shaw, and Burbacher, 1985). Iraqi children poisoned through the consumption of methyl mercury containing food products (grains treated with mercury containing fungicides) exhibited nervous system impairment, visual and auditory disorders, weakness, marked motor and cognitive impairment, and emotional disturbances (Bakir et al., 1973; Bakir et al., 1978). Individuals in Japan experienced many of these same symptoms after the ingestion of fish containing large amounts of methyl mercury. Similarly, autopsies conducted on deceased Japanese in the Minamata Bay have shown pronounced brain lesions, cerebral atrophy, edema, and gliosis in the deeper fissures (sulci) of the brain, such as in the visual cortex (Takeuchi 1968). The Japan and Iraq epidemics have clearly established mercury as an agent that can disrupt developmental processes in the unborn, and infantile, individual. Methyl mercury can pass through the placental barrier and produce many deleterious effects on the unborn fetus (Mottet, Shaw and Burbacher 1985). Children born to mercury poisoned mothers were of smaller total weight, had decreased brain weights at birth, had fewer nerve cells in the cerebral cortex, and experienced an abnormal pattern of neuronal migration (Choi et al. 1978; Takeuchi 1968, Amin-Zake et al. 1974). Of those children that survived the epidemic, many experienced severe developmental effects like impaired motor and mental function, hearing loss, and blindness throughout their childhood (Amin-Zaki et al. 1974). Researchers have also observed a heightened incidence of cerebral palsy in children born to mothers in the Minamata Bay (Matsumoto, Koya, and Takeuchi 1965).
Mercury has recently been implicated as being a contributing factor to the increasing prevalence of autism in American children. The Autism Research Institute has focused on mercury containing vaccines (TMS) and their relationship to autism. Over 2 million individuals are affected with autism, a neurodevelopment syndrome that typically produces impairment in sociality, communication, and sensory/perceptual processes, and recent evidence has found a positive correlation between complications seen in autistics and complications seen in mercury poisoned individuals (Bernard et al., 2000). While it is difficult to ascribe causation in this case, it should not be altogether dismissed. Mercury poisoning has been implicated in the development of many other human dysfunctional states for many years. Among these are cerebral palsy, amyotrophic lateral sclerosis, Parkinson's disease, psychosis, and chronic fatigue syndrome (Adams et al., 1983; Bernard et al., 2000; Dales 1972) .
The drug in Japan carries a note listing impaired consciousness, abnormal behaviors, hallucination and other psychological and neurological symptoms as possible serious side effects. The ministry is considering making a fresh warning about them, following its decision to increase the stockpile of the drug amid growing fears about a possible pandemic of a new type of influenza as bird flu deaths rise across Asia.
© 2005 Kyodo News. All rights reserved.
http://www.japantoday.com/e/?content=news&cat=1&id=355181
Mercury (CAS#7439-97-6)
Sources of exposure: Mercury occurs primarily in two forms: organic mercury and inorganic mercury. Inorganic mercury occurs when elemental mercury is combined with chlorine, sulfur, or oxygen. Inorganic mercury and elemental mercury are both toxins that can produce a wide range of adverse health affects. Inorganic mercury is used in thermometers, barometers, dental fillings, batteries, electrical wiring and switches, fluorescent light bulbs, pesticides, fungicides, vaccines, paint, skin-tightening creams, vapors from spills, antiseptic creams, pharmaceutical drugs and ointments (Thimerisol is the mercury used in vaccines) (ATSDR, 1989a). Inorganic mercury vapor is at high concentrations near chlorine-alkali plants, smelters, municipal incinerators and sewage treatment plants. The organic form occurs when mercury is combined with carbon. The most common form of organic mercury is methyl mercury, which is produced primarily by small organisms in water and soil when they are exposed to inorganic mercury. Humans also have the ability to convert inorganic mercury to an organic form once it has become absorbed into the bloodstream. Organic mercury is known to bioaccumulate -- or pass up the food chain due an organism's inability to process and eliminate it. It is found primarily in marine life (fish), and can often be found in produce and farm animals, processed grains and dairy products, and surface, salt-, and fresh water sources (ATSDR, 1989a; Brenner and Snyder, 1980). Occupational exposure to mercury containing compounds presents a significant health risk to individuals. Dentists, painters, fisherman, electricians, pharmaceutical/laboratories workers, farmers, factory workers, miners, chemists and beauticians are just some of the professions chronically exposed to mercury compounds.
Target tissues: The absorption and distribution of mercury compounds depends largely upon its chemical state. Organic mercury compounds are absorbed from the gastrointestinal tract more readily than inorganic mercury compounds, with the latter being very poorly absorbed. After absorption in the gastrointestinal tract, organic mercury is readily distributed throughout the body but tends to concentrate in the brain and kidneys (Goyer, 1991b). Approximately 80% of mercury vapor is absorbed directly through the lungs and distributed primarily to the CNS and the kidneys (Friberg and Nordberg, 1973). Inorganic and organic forms of mercury have also been seen in the red blood cells, liver, muscle tissue, and gall bladder (Peterson et al., 1991, Dutczak et al., 1991, ATSDR 1989a).
Signs and symptoms: Mercury exposure can result in a wide variety of human health conditions. The degree of impairment and the clinical manifestations that accompany mercury exposure largely depend upon its chemical state and the route of exposure. While inorganic mercury compounds are considered less toxic than organic mercury compounds (primarily due to difficulties in absorption), inorganic mercury that is absorbed is readily converted to an organic form by physiological processes in the liver.
The acute ingestion of inorganic mercury salts may cause gastrointestinal disorders such as abdominal pain, vomiting, diarrhea, and hemorrhage (ATSD 1989a). Repeated and prolonged exposure has resulted in severe disturbances in the central nervous system, gastrointestinal tract, kidneys, and liver. Daivs et al. (1974) reported dementia, colitis, and renal failure in individuals chronically poisoned due to the ingestion of an inorganic mercury containing laxative. Inhaled inorganic mercury can cause a wide range of clinical complications in individuals including corrosive bronchitis, interstitial pneumonitis, renal disorders, fatigue, insomnia, loss of memory, excitability, chest pains, impairment of pulmonary function and gingivitis (Goyer 1991b, ATSDR 1989a). Chronic inhalation of inorganic mercury compounds may result in a reduction of sensory and motor nerve function, depression, visual and/or auditory hallucinations, muscular tremors, sleep disorders, alterations in autonomic function (heart rate, blood pressure, reflexes), impaired visuomotor coordination, speech disorders, dementia, coma and death (Clarkson 1989; Goyer 1991b; Fawyer et al. 1983; Piikivi and Hanninen 1989; and Ngim et al. 1992). Ngim et al. (1992) have shown that a group of dentists exposed to mercury vapors occupationally perform significantly worse in neurobehavioral tests that measure motor speed, visual scanning, visuomotor coordination and concentration, verbal memory and visual memory. Kishi et al. (1993) have found that smelter workers exposed to inorganic mercury compounds continue to experience neurological symptoms-tremors, headaches, slurred speech-senile symptoms and diminished mental capacities eighteen years after the cessation of mercury exposure.
Our understanding of the effects of methyl mercury poisoning comes primarily from epidemic poisonings in Iraq and Japan. In iraq, more than 6,000 individuals were hospitalized and 459 died as a result of methyl mercury poisoning. Adults experienced symptoms including parasthesia, visual disorders, ataxia, fatigue, tremor, hearing disorders (deafness) and coma (Bakir et al., 1973; Mottet, Shaw, and Burbacher, 1985). Neuropathologic observations of exposed individuals have shown irreversible brain damage including neuronal necrosis, cerebral edema, gliosis, and cerebral atrophy (Mottet, Shaw, and Burbacher, 1985). Iraqi children poisoned through the consumption of methyl mercury containing food products (grains treated with mercury containing fungicides) exhibited nervous system impairment, visual and auditory disorders, weakness, marked motor and cognitive impairment, and emotional disturbances (Bakir et al., 1973; Bakir et al., 1978). Individuals in Japan experienced many of these same symptoms after the ingestion of fish containing large amounts of methyl mercury. Similarly, autopsies conducted on deceased Japanese in the Minamata Bay have shown pronounced brain lesions, cerebral atrophy, edema, and gliosis in the deeper fissures (sulci) of the brain, such as in the visual cortex (Takeuchi 1968). The Japan and Iraq epidemics have clearly established mercury as an agent that can disrupt developmental processes in the unborn, and infantile, individual. Methyl mercury can pass through the placental barrier and produce many deleterious effects on the unborn fetus (Mottet, Shaw and Burbacher 1985). Children born to mercury poisoned mothers were of smaller total weight, had decreased brain weights at birth, had fewer nerve cells in the cerebral cortex, and experienced an abnormal pattern of neuronal migration (Choi et al. 1978; Takeuchi 1968, Amin-Zake et al. 1974). Of those children that survived the epidemic, many experienced severe developmental effects like impaired motor and mental function, hearing loss, and blindness throughout their childhood (Amin-Zaki et al. 1974). Researchers have also observed a heightened incidence of cerebral palsy in children born to mothers in the Minamata Bay (Matsumoto, Koya, and Takeuchi 1965).
Mercury has recently been implicated as being a contributing factor to the increasing prevalence of autism in American children. The Autism Research Institute has focused on mercury containing vaccines (TMS) and their relationship to autism. Over 2 million individuals are affected with autism, a neurodevelopment syndrome that typically produces impairment in sociality, communication, and sensory/perceptual processes, and recent evidence has found a positive correlation between complications seen in autistics and complications seen in mercury poisoned individuals (Bernard et al., 2000). While it is difficult to ascribe causation in this case, it should not be altogether dismissed. Mercury poisoning has been implicated in the development of many other human dysfunctional states for many years. Among these are cerebral palsy, amyotrophic lateral sclerosis, Parkinson's disease, psychosis, and chronic fatigue syndrome (Adams et al., 1983; Bernard et al., 2000; Dales 1972) .
Wednesday, November 9, 2005
Supreme Court RejectsCell Phone Radiation Appeal
Well folks, here we are, getting closer to the cell phone facts that harm your health. These harmful radiation emitting units will never be looked at in the same way again. This is, as I predicted, tobacco II.
Class action lawsuits against cell phone makers over radiation emissions will be able to go forward, after the U.S. Supreme Court on Monday declined to hear an appeal by the companies.
The high court rejected hearing an appeal by companies like Nokia and Cingular Wireless challenging a decision by a U.S. appeals court that reinstated the lawsuits that argued manufacturers knew about and hid the risks of radiation emissions wireless phones posed to users.
Wireless phones are radios that emit frequency radiation, and in the United States the Federal Communications Commission must approve any device that sends out such radiation.
Exposure to high levels of radiation can cause adverse health effects, but it is less clear the impact on a wireless phone user who is exposed to low levels of radiation when a phone is held to an ear directly.
Health advocates have expressed concerns about radiation causing problems ranging from headaches to tumors. But the wireless industry has pointed to U.S. government statements that scientific evidence so far has not shown any health problems associated with wireless phone use.
Five class action lawsuits were filed in state courts seeking damages, including money for wireless users to buy a headset or reimburse those who had already had purchased one.
A U.S. district court judge dismissed the five lawsuits on the grounds that state regulation of wireless phone emissions was pre-empted by the FCC, but the U.S. Court of Appeals for the 4th Circuit overturned that decision and reinstated the cases.
The wireless industry is worried about being required to adhere to numerous different emissions requirements imposed by states, something the service providers and manufacturers argue would wreak havoc on the industry and consumers.
"This court's intervention is necessary to prevent the balkanisation of network standards...which will, if uncorrected, undermine the ability of consumers to use an FCC-approved wireless telephone in every state of the union," they said in their appeal to the high court.
Other companies that joined in the appeal include Motorola and Qualcomm. Cingular Wireless is a joint venture of BellSouth and SBC Communications
As a result of the high court's action, one lawsuit will go forward in federal court while the four other lawsuits will go forward in state court.
Copyright © 2005 Reuters Limited. All rights reserved.
***
Class action lawsuits against cell phone makers over radiation emissions will be able to go forward, after the U.S. Supreme Court on Monday declined to hear an appeal by the companies.
The high court rejected hearing an appeal by companies like Nokia and Cingular Wireless challenging a decision by a U.S. appeals court that reinstated the lawsuits that argued manufacturers knew about and hid the risks of radiation emissions wireless phones posed to users.
Wireless phones are radios that emit frequency radiation, and in the United States the Federal Communications Commission must approve any device that sends out such radiation.
Exposure to high levels of radiation can cause adverse health effects, but it is less clear the impact on a wireless phone user who is exposed to low levels of radiation when a phone is held to an ear directly.
Health advocates have expressed concerns about radiation causing problems ranging from headaches to tumors. But the wireless industry has pointed to U.S. government statements that scientific evidence so far has not shown any health problems associated with wireless phone use.
Five class action lawsuits were filed in state courts seeking damages, including money for wireless users to buy a headset or reimburse those who had already had purchased one.
A U.S. district court judge dismissed the five lawsuits on the grounds that state regulation of wireless phone emissions was pre-empted by the FCC, but the U.S. Court of Appeals for the 4th Circuit overturned that decision and reinstated the cases.
The wireless industry is worried about being required to adhere to numerous different emissions requirements imposed by states, something the service providers and manufacturers argue would wreak havoc on the industry and consumers.
"This court's intervention is necessary to prevent the balkanisation of network standards...which will, if uncorrected, undermine the ability of consumers to use an FCC-approved wireless telephone in every state of the union," they said in their appeal to the high court.
Other companies that joined in the appeal include Motorola and Qualcomm. Cingular Wireless is a joint venture of BellSouth and SBC Communications
As a result of the high court's action, one lawsuit will go forward in federal court while the four other lawsuits will go forward in state court.
Copyright © 2005 Reuters Limited. All rights reserved.
Sunday, October 23, 2005
Looking for a Little Sleep?
A 2003 study identified about 55% of those 18-49 own and frequently use cell phones. One of the major identified health complaints from exposure to EMF/ELF is insomnia. Now we see this report identifying the rising use of drugs and OTC products for sleep. Of course I would include poor nutrition, environmental pollution and stress as related factors. But really, now, what I want to clearly focus on here is the problems with radiation exposure from things that cause EMF/ELF exposure.
I’ve figured that there is an increasing number of health issues not being able to get a diagnosis for quite a few years. My prognostication has been to raise the Canary in the coal mine to react to electrical sensitivity syndrome. While this is as real as MCS (folks with MCS have a greater risk of ESS), although the Asthma and Allergy professional organizations say otherwise, I’m reminding them that IgE readings go up when dust is ionized. IgE is an allergy marker in blood. Now just how is it that dust is ionized? Why cell phone mast towers and cell phones, digital tv towers and microwave proliferation of course. But then you learned that in 8th grade science didn’t you?
I hope you’ll begin to see the same connections after reading the comments and reports that follow…
Prescription sleep aid use soaring in US: study
By Bill Berkrot
NEW YORK (Reuters) - The number of younger Americans reaching for prescription drugs to get a good night's sleep and the money being spent to keep from tossing and turning, is soaring, according to a study conducted by a prescription management company.
Among adults aged 20 to 44, use of sleep medications doubled between 2000 and 2004, while spending among the age group for a restful night jumped 190 percent over that period, the Medco Health Solutions study released on Monday found.
The numbers were even more startling among children aged 10 to 19 with use of sleep aids up 85 percent and spending up a whopping 223 percent over 2000 levels.
Medco's data analysis from the first six months of 2004 showed that 15 percent of the children taking sleep medicines were also using drugs to treat attention deficit/hyperactivity disorder, but it was not clear whether the disorder or the medication treating it was causing the sleep problems.
The study also found that women among all age groups were far more likely to use sleep aids than men, with the largest disparity -- 58 percent higher -- among women ages 20 to 64.
"Although the elderly are still the most frequent users of sleeping aids, the evidence found in this study shows that younger adults and children are starting to use these medications with even greater frequency," said Dr. Robert Epstein, Medco's chief medical officer.
"The pattern of insomnia in children reflects difficulty in getting to sleep, whereas with adults it's a problem staying asleep," Epstein said.
More than 70 million people in the United States may be affected by a sleep problem, such as insomnia or sleep apnea, with some 60 percent of them suffering from a chronic sleep disorder, according to the National Institutes of Health.
Sleep drugs have clearly become big business and Epstein said there was every reason to believe the trends seen in the Medco study would continue to accelerate as new medicines come to market.
Americans filled more than 35 million prescriptions for sleeping pills in 2004, spending $2.1 billion, Medco said, citing NIH statistics.
Global Sales of Ambien, the world's most popular prescription sleep drug made by Sanofi-Aventis, hit $1.76 billion in 2004.
The Medco study reviewed prescription drug claims of 2.4 million Americans between 2000 and 2004.
Excerpts for a 56 page report completed by a Canadian researcher holding a PhD who is a Professional Engineer:
Oft-reported visible conditions that are linked to EMF exposure are memory loss, allergic reactions, insomnia, dizziness, forgetfulness, anxiety, nausea, skin rash, chronic fatigue syndrome, stress, and high blood pressure along with many more serious invisible conditions like childhood leukemia. The latency periods of some EMF-caused diseases are 20 to 30 years.
“The ICNIRP (International Commission on Non-Ionizing Radiation Protection) guidelines were not formulated by scientists, but by technicians calculating how long it would take to heat a bag of sugar through one degree Celsius. This absurdity is all that stands between us and the risk of life threatening or chronic disease. The ICNIRP guidelines only measure the immediate and very short term thermal (heating) effect of radiation, not the long term biological effect, which is the main threat to health.” (6)
Robert Kane the author of ‘Cellular telephone Russian Roulette’ Report wrote, “In fact, the scattering of ionizing radiation throughout biological tissue efficiently breaks the covalent bonds that are the basis for construction of organic molecules” “Clearly, by now we must all agree that it is not necessary to ionize a DNA molecule to disrupt one or more of the molecule’s covalent bonds.” “In essence the effects can be identical - the disruption of covalent bonds is essentially what destroys DNA molecules and genetic information and leads to neo-plastic transformation of cells.” (77) D. L. Henshaw reported, “We present the hypothesis that exposure to power frequency magnetic fields causes increased risk of childhood leukaemia via the disruption of the nocturnal production of melatonin in the pineal gland.” “Melatonin is an antioxidant effective in protecting nuclear DNA, membrane lipids and possibly cytosolic proteins from oxidative damage.” Here EMFs were implicated melatonin disruption and eventual DNA damages. Henry Lai was the first to show that power-frequency EMF can cause both single and double-strand DNA breaks and later REFLEX confirmed it. It seems more likely either disruption of molecule’s covalent bonds or reduced melatonin production by low-level EMFs or both lead to DNA damages and eventual cancer initiation.
175 German doctors and country-wide lady doctors are combining together to put forward their observations of adverse health effects from pulsed high-frequency EMFs (microwave) to the Prime Minister Edmund Stolber. They have found the medical complaints of 356 people who have had long-term [radiation] exposure at far below the limit of thermal effects from mobile phone base station and DECT telephones. The people suffer from one, several or many of the following symptoms, like “sleep disturbances, tiredness, disturbance in concentration, forgetfulness, problem
with finding words, depressive mood, ear noises, sudden loss of hearing, hearing loss, giddiness, nose bleeds, visual disturbances, frequent infections, sinusitis, joint and limb pains, nerve and soft tissue pains, feeling of numbness, heart rhythm disturbances, increased blood pressure episodes, hormonal disturbances, night-time sweats, nausea” July 10, 2005 (56)
•Chronic or intractable medical problems associated with prolonged exposure to unsuspected harmful environmental electric, magnetic or electro-magnetic fields radiating in the bedroom or workplace and their exacerbation by intake of harmful light and heavy metals from common sources.
Omura Y, Losco M, Omura AK, Yamamoto S, Ishikawa H, Takeshige C, Shimotsuura Y, Muteki T. Heart Disease Research Foundation, New York.
Unsuspected prolonged exposure to abnormal environmental (very high frequency) electro-magnetic fields (EMF), electric fields (EF) or magnetic fields (MF) at 60 Hz or 16K Hz in the bedroom or workplace may contribute to the development of various intractable medical problems. Most of the clinical symptoms appear when the individuals are exposed to EMF for many hours a day for at least several months to 1-year for relatively benign diseases or symptoms (such as intractable pain or medical problems), or several to over 10 years for more serious diseases (such as cancers of the digestive system or other organs), all of which seem to appear with the additional co-existence of micro-circulatory disturbances with Thromboxane B2 (TXB2), bacterial or viral infections and decrease or absence of acetylcholine, and lead, mercury, or aluminum deposits, with or without asbestos. These abnormal environmental EMF's or EF's can be detected by the Bi-Digital O-Ring Test, which has good correlation with standard laboratory measurement, especially with EF measurement, and the distribution of EMF often includes a linear band-like appearance on the abnormal part of the patient's body, as well as on the patient's corresponding area of the bed, or at the workplace. These EMF's can be eliminated either by a metal sheet, acting as a reflector, which redirects the harmful EMF or eliminates it completely by grounding the metal sheet at high frequency range, while extremely low frequency (ELF) magnetic fields at the near field are more difficult to eliminate. Several examples of medical problems that appear to be associated with repeated and prolonged exposure to abnormal environmental EMF, EF or MF are summarized in this article. EF or MF-induced abnormalities were artificially and reversibly created in humans by exposing the extremities or head to a 10Volt/Meter (V/M) EF at 60 Hz about 33 (evening) to 50 cm (daytime or after midnight) from a pair of rubber insulated wires connected to an AC source, but where no current is passed, so that no extra MF exists. After exposing normal parts of the extremities and head to a 10 V/M EF for 5 minutes, abnormal increase of TXB2 and disappearance or significant reduction of acetylcholine was observed for 5 minutes, and slightly longer abnormal time duration was observed in those who have aluminum, lead, or mercury deposits. This indicates that the upper limit of relatively safe EF should be around 10V/M at 60 Hz rather than 25V/M at ELF by Swedish Government recommendation, which is now widely accepted.
Publication Types: * Case Reports
PMID: 1685623 [PubMed - indexed for MEDLINE]
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=1685623&dopt=Abstract
•From Swedish researcher Olle Johansson, assoc. prof.
The Experimental Dermatology Unit Department of Neuroscience Karolinska Institute
171 77 Stockholm Description of symptoms as well as occurrence of IgE and positive Phadiatop Combi in persons with the physical impairment electrohypersensitivity Please, note that I have got yet another article published - in Swedish only [the title is translated below into English]:
Holmboe G, Johansson O, "Symptombeskrivning samt förekomst av IgE och positiv Phadiatop Combi hos personer med funktionsnedsättningen elöverkänslighet", (="Description of symptoms as well as occurrence of IgE and positive Phadiatop Combi in persons with the physical impairment electrohypersensitivity", in Swedish), Medicinsk Access 2005; 1 (5): 58-63
http://www.medicinskaxess.se/nr5/eloverkanslighet5.pdf
I’ve figured that there is an increasing number of health issues not being able to get a diagnosis for quite a few years. My prognostication has been to raise the Canary in the coal mine to react to electrical sensitivity syndrome. While this is as real as MCS (folks with MCS have a greater risk of ESS), although the Asthma and Allergy professional organizations say otherwise, I’m reminding them that IgE readings go up when dust is ionized. IgE is an allergy marker in blood. Now just how is it that dust is ionized? Why cell phone mast towers and cell phones, digital tv towers and microwave proliferation of course. But then you learned that in 8th grade science didn’t you?
I hope you’ll begin to see the same connections after reading the comments and reports that follow…
Prescription sleep aid use soaring in US: study
By Bill Berkrot
NEW YORK (Reuters) - The number of younger Americans reaching for prescription drugs to get a good night's sleep and the money being spent to keep from tossing and turning, is soaring, according to a study conducted by a prescription management company.
Among adults aged 20 to 44, use of sleep medications doubled between 2000 and 2004, while spending among the age group for a restful night jumped 190 percent over that period, the Medco Health Solutions study released on Monday found.
The numbers were even more startling among children aged 10 to 19 with use of sleep aids up 85 percent and spending up a whopping 223 percent over 2000 levels.
Medco's data analysis from the first six months of 2004 showed that 15 percent of the children taking sleep medicines were also using drugs to treat attention deficit/hyperactivity disorder, but it was not clear whether the disorder or the medication treating it was causing the sleep problems.
The study also found that women among all age groups were far more likely to use sleep aids than men, with the largest disparity -- 58 percent higher -- among women ages 20 to 64.
"Although the elderly are still the most frequent users of sleeping aids, the evidence found in this study shows that younger adults and children are starting to use these medications with even greater frequency," said Dr. Robert Epstein, Medco's chief medical officer.
"The pattern of insomnia in children reflects difficulty in getting to sleep, whereas with adults it's a problem staying asleep," Epstein said.
More than 70 million people in the United States may be affected by a sleep problem, such as insomnia or sleep apnea, with some 60 percent of them suffering from a chronic sleep disorder, according to the National Institutes of Health.
Sleep drugs have clearly become big business and Epstein said there was every reason to believe the trends seen in the Medco study would continue to accelerate as new medicines come to market.
Americans filled more than 35 million prescriptions for sleeping pills in 2004, spending $2.1 billion, Medco said, citing NIH statistics.
Global Sales of Ambien, the world's most popular prescription sleep drug made by Sanofi-Aventis, hit $1.76 billion in 2004.
The Medco study reviewed prescription drug claims of 2.4 million Americans between 2000 and 2004.
***
Excerpts for a 56 page report completed by a Canadian researcher holding a PhD who is a Professional Engineer:
Oft-reported visible conditions that are linked to EMF exposure are memory loss, allergic reactions, insomnia, dizziness, forgetfulness, anxiety, nausea, skin rash, chronic fatigue syndrome, stress, and high blood pressure along with many more serious invisible conditions like childhood leukemia. The latency periods of some EMF-caused diseases are 20 to 30 years.
“The ICNIRP (International Commission on Non-Ionizing Radiation Protection) guidelines were not formulated by scientists, but by technicians calculating how long it would take to heat a bag of sugar through one degree Celsius. This absurdity is all that stands between us and the risk of life threatening or chronic disease. The ICNIRP guidelines only measure the immediate and very short term thermal (heating) effect of radiation, not the long term biological effect, which is the main threat to health.” (6)
Robert Kane the author of ‘Cellular telephone Russian Roulette’ Report wrote, “In fact, the scattering of ionizing radiation throughout biological tissue efficiently breaks the covalent bonds that are the basis for construction of organic molecules” “Clearly, by now we must all agree that it is not necessary to ionize a DNA molecule to disrupt one or more of the molecule’s covalent bonds.” “In essence the effects can be identical - the disruption of covalent bonds is essentially what destroys DNA molecules and genetic information and leads to neo-plastic transformation of cells.” (77) D. L. Henshaw reported, “We present the hypothesis that exposure to power frequency magnetic fields causes increased risk of childhood leukaemia via the disruption of the nocturnal production of melatonin in the pineal gland.” “Melatonin is an antioxidant effective in protecting nuclear DNA, membrane lipids and possibly cytosolic proteins from oxidative damage.” Here EMFs were implicated melatonin disruption and eventual DNA damages. Henry Lai was the first to show that power-frequency EMF can cause both single and double-strand DNA breaks and later REFLEX confirmed it. It seems more likely either disruption of molecule’s covalent bonds or reduced melatonin production by low-level EMFs or both lead to DNA damages and eventual cancer initiation.
175 German doctors and country-wide lady doctors are combining together to put forward their observations of adverse health effects from pulsed high-frequency EMFs (microwave) to the Prime Minister Edmund Stolber. They have found the medical complaints of 356 people who have had long-term [radiation] exposure at far below the limit of thermal effects from mobile phone base station and DECT telephones. The people suffer from one, several or many of the following symptoms, like “sleep disturbances, tiredness, disturbance in concentration, forgetfulness, problem
with finding words, depressive mood, ear noises, sudden loss of hearing, hearing loss, giddiness, nose bleeds, visual disturbances, frequent infections, sinusitis, joint and limb pains, nerve and soft tissue pains, feeling of numbness, heart rhythm disturbances, increased blood pressure episodes, hormonal disturbances, night-time sweats, nausea” July 10, 2005 (56)
•Chronic or intractable medical problems associated with prolonged exposure to unsuspected harmful environmental electric, magnetic or electro-magnetic fields radiating in the bedroom or workplace and their exacerbation by intake of harmful light and heavy metals from common sources.
Omura Y, Losco M, Omura AK, Yamamoto S, Ishikawa H, Takeshige C, Shimotsuura Y, Muteki T. Heart Disease Research Foundation, New York.
Unsuspected prolonged exposure to abnormal environmental (very high frequency) electro-magnetic fields (EMF), electric fields (EF) or magnetic fields (MF) at 60 Hz or 16K Hz in the bedroom or workplace may contribute to the development of various intractable medical problems. Most of the clinical symptoms appear when the individuals are exposed to EMF for many hours a day for at least several months to 1-year for relatively benign diseases or symptoms (such as intractable pain or medical problems), or several to over 10 years for more serious diseases (such as cancers of the digestive system or other organs), all of which seem to appear with the additional co-existence of micro-circulatory disturbances with Thromboxane B2 (TXB2), bacterial or viral infections and decrease or absence of acetylcholine, and lead, mercury, or aluminum deposits, with or without asbestos. These abnormal environmental EMF's or EF's can be detected by the Bi-Digital O-Ring Test, which has good correlation with standard laboratory measurement, especially with EF measurement, and the distribution of EMF often includes a linear band-like appearance on the abnormal part of the patient's body, as well as on the patient's corresponding area of the bed, or at the workplace. These EMF's can be eliminated either by a metal sheet, acting as a reflector, which redirects the harmful EMF or eliminates it completely by grounding the metal sheet at high frequency range, while extremely low frequency (ELF) magnetic fields at the near field are more difficult to eliminate. Several examples of medical problems that appear to be associated with repeated and prolonged exposure to abnormal environmental EMF, EF or MF are summarized in this article. EF or MF-induced abnormalities were artificially and reversibly created in humans by exposing the extremities or head to a 10Volt/Meter (V/M) EF at 60 Hz about 33 (evening) to 50 cm (daytime or after midnight) from a pair of rubber insulated wires connected to an AC source, but where no current is passed, so that no extra MF exists. After exposing normal parts of the extremities and head to a 10 V/M EF for 5 minutes, abnormal increase of TXB2 and disappearance or significant reduction of acetylcholine was observed for 5 minutes, and slightly longer abnormal time duration was observed in those who have aluminum, lead, or mercury deposits. This indicates that the upper limit of relatively safe EF should be around 10V/M at 60 Hz rather than 25V/M at ELF by Swedish Government recommendation, which is now widely accepted.
Publication Types: * Case Reports
PMID: 1685623 [PubMed - indexed for MEDLINE]
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=1685623&dopt=Abstract
•From Swedish researcher Olle Johansson, assoc. prof.
The Experimental Dermatology Unit Department of Neuroscience Karolinska Institute
171 77 Stockholm Description of symptoms as well as occurrence of IgE and positive Phadiatop Combi in persons with the physical impairment electrohypersensitivity Please, note that I have got yet another article published - in Swedish only [the title is translated below into English]:
Holmboe G, Johansson O, "Symptombeskrivning samt förekomst av IgE och positiv Phadiatop Combi hos personer med funktionsnedsättningen elöverkänslighet", (="Description of symptoms as well as occurrence of IgE and positive Phadiatop Combi in persons with the physical impairment electrohypersensitivity", in Swedish), Medicinsk Access 2005; 1 (5): 58-63
http://www.medicinskaxess.se/nr5/eloverkanslighet5.pdf
Wednesday, October 19, 2005
FACTORY FARMING MAY BE ROOT CAUSE OF BIRD FLU EPIDEMIC
Migrating birds are being blamed for bird flu, yet for the past 60 years literally billions of broiler chickens & laying hens are kept in confined spaces. The only way they keep them alive is by an army of drugs, including antibiotics, in their feed. These birds have seriously compromised immune systems - yet we are surprised by the bird flu epidemic.
From the UK Press today.
From the UK Press today.
Subscribe to:
Posts (Atom)
